GB0502277D0 - Novel imaging agents - Google Patents

Novel imaging agents

Info

Publication number
GB0502277D0
GB0502277D0 GBGB0502277.7A GB0502277A GB0502277D0 GB 0502277 D0 GB0502277 D0 GB 0502277D0 GB 0502277 A GB0502277 A GB 0502277A GB 0502277 D0 GB0502277 D0 GB 0502277D0
Authority
GB
United Kingdom
Prior art keywords
imaging agents
novel imaging
novel
agents
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0502277.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
Amersham PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham PLC filed Critical Amersham PLC
Priority to GBGB0502277.7A priority Critical patent/GB0502277D0/en
Publication of GB0502277D0 publication Critical patent/GB0502277D0/en
Priority to US11/815,360 priority patent/US20080286201A1/en
Priority to CNA2006800110749A priority patent/CN101155602A/zh
Priority to EP06709644A priority patent/EP1853324A1/en
Priority to PCT/GB2006/000398 priority patent/WO2006082434A1/en
Priority to JP2007553702A priority patent/JP2008528672A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0502277.7A 2005-02-04 2005-02-04 Novel imaging agents Ceased GB0502277D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0502277.7A GB0502277D0 (en) 2005-02-04 2005-02-04 Novel imaging agents
US11/815,360 US20080286201A1 (en) 2005-02-04 2006-02-03 Caspase-3 Substrate Comprising Imaging Agents
CNA2006800110749A CN101155602A (zh) 2005-02-04 2006-02-03 包含胱天蛋白酶-3底物的成像剂
EP06709644A EP1853324A1 (en) 2005-02-04 2006-02-03 Caspase-3 substrate comprising imaging agents
PCT/GB2006/000398 WO2006082434A1 (en) 2005-02-04 2006-02-03 Caspase-3 substrate comprising imaging agents
JP2007553702A JP2008528672A (ja) 2005-02-04 2006-02-03 カスパーゼ−３基質含有造影剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0502277.7A GB0502277D0 (en) 2005-02-04 2005-02-04 Novel imaging agents

Publications (1)

Publication Number Publication Date
GB0502277D0 true GB0502277D0 (en) 2005-03-09

Family

ID=34307944

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0502277.7A Ceased GB0502277D0 (en) 2005-02-04 2005-02-04 Novel imaging agents

Country Status (6)

Country Link
US (1) US20080286201A1 (https=)
EP (1) EP1853324A1 (https=)
JP (1) JP2008528672A (https=)
CN (1) CN101155602A (https=)
GB (1) GB0502277D0 (https=)
WO (1) WO2006082434A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101578225B1 (ko) 2007-05-16 2015-12-17 지이 헬스케어 에이에스 영상화를 위한 표지된 ｈｇｆ 결합성 펩티드
CA2722858C (en) 2008-04-30 2017-08-29 Siemens Medical Solutions Usa, Inc. Substrate based pet imaging agents
DK2288615T3 (en) 2008-05-21 2017-09-04 Genesis Tech Ltd SELECTIVE CASPASE INHIBITORS AND APPLICATIONS THEREOF
US20110293520A1 (en) * 2008-06-09 2011-12-01 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
GB0819280D0 (en) * 2008-10-21 2008-11-26 Gen Electric Imgaing and radiotherapy methods
EP2697246B1 (en) 2011-04-15 2018-03-07 Genesis Technologies Limited Selective cysteine protease inhibitors and uses thereof
US9956260B1 (en) 2011-07-22 2018-05-01 The J. David Gladstone Institutes Treatment of HIV-1 infection and AIDS
WO2016065174A1 (en) * 2014-10-22 2016-04-28 Seed Research And Development Llc Caspase probes for detection of apoptosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2328457A1 (en) * 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
EP1379284A4 (en) * 2001-01-05 2007-07-25 Gen Hospital ACTIVE IMAGING PROBES
US6979530B2 (en) * 2001-05-21 2005-12-27 Applera Corporation Peptide conjugates and fluorescence detection methods for intracellular caspase assay
GB0327494D0 (en) * 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents

Also Published As

Publication number Publication date
EP1853324A1 (en) 2007-11-14
US20080286201A1 (en) 2008-11-20
JP2008528672A (ja) 2008-07-31
CN101155602A (zh) 2008-04-02
WO2006082434A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
GB0519391D0 (en) Imaging agents
GB2424581B (en) Formulations
GB0610395D0 (en) Novel imaging agents
EP1894510A4 (en) Borescope
GB2410566B (en) Imaging members
IL185773A0 (en) Formulations
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
GB0524987D0 (en) Novel imaging agents for fibrosis
GB0511096D0 (en) Laser imaging
GB0523506D0 (en) Novel in vivo imaging compounds
ZA200800365B (en) Substituted tetrahydroqulnolines
EP1931134A4 (en) IMAGING DEVICE
GB0517992D0 (en) Laser imaging
GB0512770D0 (en) Imaging compounds
EP1860475A4 (en) IMAGING LENS
GB0524991D0 (en) Novel imaging agents for fibrosis
GB2424585B (en) Speculum
GB0502277D0 (en) Novel imaging agents
GB2426071B (en) Document imaging
GB0522112D0 (en) Novel imaging agents for cancer
GB0504528D0 (en) Endoscope
GB2443771B (en) Speculum
GB2422543B (en) Louse-killing agents
EG24468A (en) Roylacid & Jatrocid
GB0521514D0 (en) Laser imaging

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)